Indaptus Therapeutics Inc Share Price Today: Live Updates & Key Insights

Indaptus Therapeutics Inc share price today is $1.71, up -3.41%. The stock opened at $1.78 against the previous close of $1.76, with an intraday high of $1.78 and low of $1.65.

Indaptus Therapeutics Inc Share Price Chart

Indaptus Therapeutics Inc

us-stock
To Invest in {{usstockname}}
us-stock

Indaptus Therapeutics Inc Share Price Performance

$1.71 -0.0341(-3.41%) INDP at 23 Mar 2026 01:39 PM Biotechnology
Lowest Today 1.65
Highest Today 1.78
Today’s Open 1.78
Prev. Close 1.76
52 Week High 21.84
52 Week Low 1.52
Day’s Range: Low 1.65 High 1.78
52-Week Range: Low 1.52 High 21.84
1 day return -
1 Week return -12.75
1 month return -13.63
3 month return -16.99
6 month return -39.78
1 year return +134.92
3 year return -5.52
5 year return -90.43
10 year return -

Indaptus Therapeutics Inc Institutional Holdings

Virtu Financial LLC 0.85

Abante Quant Value FI 0.41

Fidelity Extended Market Index 0.22

Tower Research Capital LLC 0.14

Spartan Total Market Index Pool G 0.03

Fidelity Series Total Market Index 0.02

UBS Group AG 0.02

Fidelity Total Market Index 0.02

NT Ext Equity Mkt Idx Fd - NL 0.01

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.01

Northern Trust Extended Eq Market Idx 0.01

NT Ext Equity Mkt Idx Fd - L 0.01

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.00

Bank of America Corp 0.00

SBI Securities Co Ltd 0.00

FMR Inc 0.00

Pine Valley Investments Ltd Liability Co 0.00

Wells Fargo & Co 0.00

Indaptus Therapeutics Inc Market Status

Strong Buy: 0

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

Indaptus Therapeutics Inc Fundamentals

Market Cap 3.81 M

PB Ratio 1.2134

PE Ratio 0.0

Enterprise Value -2.01 M

Total Assets 9.31 M

Volume 59224

Indaptus Therapeutics Inc Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:null 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-15076468 -15.1M, FY22:-13734690 -13.7M, FY21:-7693664 -7.7M, FY20:-3569037 -3.6M, FY19:null 0.0M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:null 0.0M, Q1/2025:null 0.0M, Q3/2024:null 0.0M, Q2/2024:null 0.0M

Quarterly Net worth Q3/2025:-2975117 -3.0M, Q2/2025:-5228919 -5.2M, Q1/2025:-4532430 -4.5M, Q3/2024:-3069036 -3.1M, Q2/2024:-4015267 -4.0M

About Indaptus Therapeutics Inc & investment objective

Company Information Indaptus Therapeutics, Inc., a clinical biotechnology company, engages in the development of various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate consists of Decoy20, which is used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, and chronic hepatitis B virus, and human immunodeficiency virus infection, as well as for the treatment of advanced solid tumors. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. is headquartered in New York, New York.

Organisation Biotechnology

Employees 7

Industry Biotechnology

CEO Mr. David Elliot Lazar

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Indaptus Therapeutics Inc FAQs

What is the share price of Indaptus Therapeutics Inc today?

The current share price of Indaptus Therapeutics Inc is $1.71.

Can I buy Indaptus Therapeutics Inc shares in India?

Yes, Indian investors can buy Indaptus Therapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Indaptus Therapeutics Inc shares in India?

You can easily invest in Indaptus Therapeutics Inc shares from India by:

Can I buy fractional shares of Indaptus Therapeutics Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Indaptus Therapeutics Inc?

Indaptus Therapeutics Inc has a market cap of $3.81 M.

In which sector does Indaptus Therapeutics Inc belong?

Indaptus Therapeutics Inc operates in the Biotechnology sector.

What documents are required to invest in Indaptus Therapeutics Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Indaptus Therapeutics Inc?

The PE ratio of Indaptus Therapeutics Inc is N/A and the PB ratio is 1.21.